CDM: Cyber physical version 4.0: Transformation of project management skills to handle the disruptive innovation
We all are living in the ‘Digital Age’ where primitive instances of Cyber Physical Systems (CPS) exist today. Research and technological advances have enabled implementation of the highly intangible cyber elements in hardware and infrastructures to control electrical, mechanical, structural, thermal, hydraulics, and biological components along with the processes. The onset of Cyber Physical system (CPS) will have an impact on Business and operating models within clinical trial management.
Instead of standalone processes and devices that can be designed, certified and used independently of each other to treat patients; we will have to encounter the interdependent distributed systems which will control multiple aspects of patient’s physiological and clinical data in the near future. The first and foremost important step towards this transformation is to understand the impact of this on project management and also on the holistic review of technology-aided data science. It is vital to understand how this will transmute the artificial intelligence to our day to day work. It also creates an inquisitive environment for all project managers to think if technology is a cost based differentiator or a value based differentiator
This will lead to the enduring scope for looking at the clinical trial project management where we interact with multiple stake holders who will also go through this change. It is time to think how we can be prepared to embrace these changes and also sustain our day to day operations and bring more value to this CDM industry.
Dilli Babu Shunmugam (Babu)
COO Agati Systems and Head of Operations ACI Clinical East LLP
Babu has been in the Life Sciences industry for the past 25 years and is currently running his own organizations namely Agati Systems and ACI Clinical East LLP as COO and Head of Operations respectively. He served as a member of the Organizing committee for SCDM in 2015 and also actively participated in the Organizing committee for ISCR.
As a part of his current role as a board member and Director in both the above organizations, his role is to manage the entire operations of both the companies and also play an active role in global governance. He has a graduation in Engineering and Masters in Business Administration.
He started off his career as Product Specialist in Hitachi Medical in the Medical Devices industry and has exposure to various therapeutic areas as Application Specialist. During his stint in Medical devices industry, has worked in Japan, Singapore, USA and Israel. In the early 2000, he co-founded a CRO called Biomines Research Solutions in Chennai which was later acquired by ICON Clinical and has worked in ICON as Head of Data Management for 7 years and also played a vital role in expansion of ICON across various functions in India.
Later he joined PAREXEL International, Hyderabad as Head of Data Operations and played a leadership role in Global Data Operations and also assumed Strategic leadership role in the expansion of PAREXEL India operations across different functions. He has also made speeches in various forums and notable among them was a presentation that he has made in ACDM, UK in 2009.
Vice President Data Management ICON Clinical Research
Sarvesh Singh is Vice President, Data Management in ICON Clinical Research. He is also on PhUSE Board representing Asia. As part of ICON; he is Head of Data Management team for APAC region (India & China). As part of PhUSE; he is a Board member responsible for PhUSE operations in Asia (India, China and Japan). Apart from working in India he has also lived and worked in USA and Netherlands for close to 5 years.
He completed his MBA from Rotterdam School of Management (Netherlands) and M.Sc. in Statistics from University of Delhi. Prior to joining ICON; he worked with TATA Consultancy Services for close to 10 years managing a part of their operations for Eli Lilly in USA and Astellas in Netherlands. He has also spearheaded global transition for a top Japanese pharmaceutical customer and led a virtual global team spread across India and Netherlands. He was chair of PhUSE SDE held in India in July’2014.
He is also member of scientific committee of CONSPIC. He is renowned speaker and was invited by Dutch Parliament to express his views on the topic “How Netherlands can achieve its target of Energy Efficiency by 2020”. In 2013; he visited European Commission in Brussels and heard from Director General on how EU is organized and how to do business in Europe. He was also invited by The Hague Institute for Global Justice to attend a seminar on “Dutch Foreign Policy”.
He attended ISHA INSIGHT program in Nov’2014 and got privilege to meet renowned people like Ratan Tata, Kiran Bedi, Ramcharan etc and hear their views on how to scale up businesses. He is also very actively involved with many NGOs and is a regular contributor to many of their teaching initiatives. He was invited in May’2015 for a guest lecture to address the Faculty Development Workshop in Anna University. In Oct’2015; he was invited to House of Lords, UK Parliament to attend London Global Convention.